You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

immune checkpoint

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Immune Checkpoint Inhibitor-related Cardiotoxicity

Not yet recruiting
  • Immune Checkpoint Inhibitors, Cardiotoxicity
  • Cardiac magnetic resonance
  • (no location specified)
Nov 10, 2023

EXploring Immune-related Adverse Events of Immune checkpoinT

Active, not recruiting
  • Cancer
  • +2 more
  • Immune checkpoint inhibitor
  • Paris, France
  • +1 more
Jul 5, 2023

Troponin to Detect Major Cardiovasculaire Advserse Events on

Recruiting
  • Cancer
  • +2 more
  • No intervention
  • Paris, France
    Institut Mutualiste Montsouris
Aug 22, 2023

Biliary Tract Cancer, Immune Checkpoint Inhibitor, Predictive Cancer Model Trial in Beijing (Immune Checkpoint Inhibitors)

Recruiting
  • Biliary Tract Cancer
  • +2 more
  • Immune Checkpoint Inhibitors
  • Beijing, Beijing, China
    Chinese Academy of Medical Sciences & Peking Union Medical Colle
Oct 5, 2023

Immune Checkpoint Inhibitors(ICPis)-Induced Endocrine

Completed
  • Immune Checkpoint Inhibitor
  • Endocrine Toxicity
    • Nanjing, Jiangsu, China
      First Affiliated Hospital, Nanjing Medical University
    Jan 6, 2023

    Adjuvant Immune Checkpoint Inhibitors in Postoperative

    Recruiting
    • Hepatocellular Carcinoma
    • Immune Checkpoint Inhibitors Based Adjuvant therapy
    • Nanning, Guangxi, China
      Jian-Hong Zhong
    Jan 18, 2023

    NSCLC Associated With Leptomeningeal Metastases Trial (Tislelizumab, pemetrexed)

    Not yet recruiting
    • NSCLC Associated With Leptomeningeal Metastases
    • Tislelizumab, pemetrexed
    • (no location specified)
    Nov 21, 2023

    Inflammatory Arthritis, Immune-related Adverse Event Trial (Adalimumab, Prednisone)

    Not yet recruiting
    • Inflammatory Arthritis
    • Immune-related Adverse Event
    • (no location specified)
    Sep 13, 2023

    Anti-cancer Immune Checkpoint Inhibition TowardsBetter

    Not yet recruiting
    • Cancer
      • (no location specified)
      Aug 1, 2023

      Immune Checkpoint Inhibitor Monotherapy or Combined With

      Not yet recruiting
      • Immune Checkpoint Inhibitor Monotherapy or Combined With Molecular Targeting Drugs / Locoregional Therapy for Hepatocellular Carcinoma
      • Immune checkpoint inhibitor
      • Guangzhou, Guangdong, China
        Department of Minimally Invasive and Interventional Radiology, L
      Jan 30, 2023

      Pre-transplant ICI Exposure and Post-transplant Graft Rejection

      Recruiting
      • Graft Rejection
      • +3 more
      • Immune checkpoint inhibitor
      • Guangzhou, Guangdong, China
        Organ Transplantation Center, Sun Yat-sen Memorial Hospital, Sun
      Jun 21, 2023

      Gastrointestinal Tumor Trial in Hangzhou (Water-filtered infrared A radiation whole-body hyperthermia (HECKEL 3000MT-4T,

      Completed
      • Gastrointestinal Tumor
      • Water-filtered infrared A radiation whole-body hyperthermia (HECKEL 3000MT-4T, Germany)
      • tislelizumab (BeiGene, China) combined with PD-1 inhibitor
      • Hangzhou, China
        Zhejiang Hospital
      Sep 1, 2023

      Immunotherapy, Immune Checkpoint Inhibitors, Immune-related Adverse Event Trial in Amiens (blood retriewal)

      Recruiting
      • Immunotherapy
      • +5 more
      • blood retriewal
      • Amiens, Picardie, France
        CHU Amiens Picardie
      Apr 3, 2023

      And Immuno-meDIated Adverse Events in Anti-cancer

      Not yet recruiting
      • Cancer
        • (no location specified)
        Jun 26, 2023

        Non Small Cell Lung Cancer Trial in Brussels (FAPI PET/CT)

        Recruiting
        • Non Small Cell Lung Cancer
        • FAPI PET/CT
        • Brussels, Belgium
          Institut Jules Bordet
        Oct 24, 2023

        Development ofEORTC Immune Checkpoint Inhibitor-specific Quality

        Recruiting
        • Cancer
        • +2 more
          • Paris, France
            Institut Curie
          Nov 2, 2022

          Immune Checkpoint Inhibitor, Lung Cancer, Liver Biomarkers Trial in Amiens (Blood sample)

          Recruiting
          • Immune Checkpoint Inhibitor
          • +3 more
          • Blood sample
          • Amiens, France
            CHU Amiens
          Dec 8, 2022

          Stage IV NSCLC Trial in Houston (Poly ICLC, IVIG)

          Not yet recruiting
          • Stage IV NSCLC
          • Houston, Texas
            Michael E. DeBakey VA Medical Center, Houston, TX
          Sep 28, 2023

          Renal Cell Carcinoma, Bladder Cancer, MSI-H Cancer Trial in Paris (Arterial Doppler for Flow Mediated Reserve measurement)

          Recruiting
          • Renal Cell Carcinoma
          • +3 more
          • Arterial Doppler for Flow Mediated Reserve measurement
          • Paris, France
            INstitut Mutualiste Montsouris
          Aug 29, 2023

          Advanced Solid Tumor Trial (INCB099280)

          Not yet recruiting
          • Advanced Solid Tumor
          • (no location specified)
          May 19, 2023

          Malignant Ascites Trial in Taichung (Nivolumab, Pembrolizumab)

          Enrolling by invitation
          • Malignant Ascites
          • Taichung, Please Select, Taiwan
            China Medical University Hospital
          Feb 16, 2023

          Hepatocellular Carcinoma Trial in Shanghai (Anlotinib and TQB2450)

          Not yet recruiting
          • Hepatocellular Carcinoma
          • Anlotinib and TQB2450
          • Shanghai, Shanghai, China
            Zhongshan hospital
          Sep 4, 2023

          ICIs Plus Angiogenesis Inhibitors for Treatment of Advanced

          Completed
          • NSCLC
          • Immune checkpoint inhibitors plus angiogenesis inhibitors
          • Immune checkpoint inhibitors without angiogenesis inhibitors
          • Suzhou, Jiangsu, China
            The Affiliated Suzhou Hospital of Nanjing Medical University
          Jan 17, 2023

          Multiple Myeloma Trial in Rennes (Blood and bone marrow sampling)

          Completed
          • Multiple Myeloma
          • Blood and bone marrow sampling
          • Rennes, France
            CHU Rennes
          Feb 2, 2023

          Fibrolamellar Hepatocellular Carcinoma Trial in Tuebingen (Fusion-VAC-XS15)

          Not yet recruiting
          • Fibrolamellar Hepatocellular Carcinoma
          • Tuebingen, Baden-Würtemberg, Germany
            University Hospital Tuebingen
          Jun 29, 2023